Pharm Sci Seminar – Michael Sailor, PhD
The effective treatment of antibiotic-resistant bacterial infections is an unmet clinical need that is of increasing urgency. The deployment of nanoparticles, specifically targeted to the diseased tissues and carrying payloads designed to either enhance existing therapeutic regimens or to reprogram the immune system response will be described.